NASDAQ
Estrella Immunopharma, Inc. (ESLA) has a current ratio of 0.12x as of Monday, May 25, 2026. This represents a 98.37% decrease compared to its 12-month average of 7.61x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.